XEnd's mission is to reduce the incidence of infection and contamination caused by hypodermic needles as they penetrate the exterior surfaces of the body.
XEnd is a Utah LLC with proprietary technology that prevents skin bacteria from contaminating blood samples. The patented “XEnd Needle” eliminates blood culture "false positives," speeding up identification of sepsis-causing pathogens. The XEnd needle will save lives, drive better patient outcomes and lower healthcare costs by $9 BN. XEnd operates as a virtual company with two employees and multiple outsourced providers.